Method of treating an autoimmune disease, which comprises a Modulator or adminsitrar S1P receptor agonist, useful in Multiple Sclerosis； a Kit.

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

WALLSTROEM ERIK

申请号：

CL2014000991

公开号：

CL2014000991A1

申请日:

2014.04.17

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

This invention relates to a method of treating multiple sclerosis in a mammalian patient, preferably a human, in need of such treatment, comprising administering to said human an S1P receptor modulator or agonist according to a dosing regimen that is determined with reference to the patient's blood lymphocyte count.MÉTODO DE TRATAMIENTO DE ESCLEROSIS MÚLTIPLE QUE COMPRENDE ADMINISTRAR AL PACIENTE EL COMPUESTO ÁCIDO 1-{4-[1-(4-CICLOHEXIL-3-(TRIFLUOROMETIL)BENZILOXIIMINO)ETIL]-2-ETILBENCIL}AZETIDIN-3-CARBOXILICO (SIPONIMOD), DE ACUERDO A UN RÉGIMEN DE DOSIFICACIÓN QUE SE DETERMINA CON REFERENCIA AL CONTEO DE LINFOCITOS EN LA SANGRE DEL PACIENTE.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/